Mevrometostat/Placebo + Enzalutamide in previously treated prostate cancer patients

A Phase 3, Randomized, Double-blind, PlaceboControlled Study Of Mevrometostat (PF-06821497) With Enzalutamide In Metastatic Castration-sensitive Prostate Cancer (MEVPRO-3)

Disease Types: Prostate

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 3, Randomized, Double-blind, PlaceboControlled Study Of Mevrometostat (PF-06821497) With Enzalutamide In Metastatic Castration-sensitive Prostate Cancer (MEVPRO-3)

For More Information:

https://clinicaltrials.gov/study/NCT07028853?term=MEVROMETOSTAT%20in%20prostate&rank=2